A medical perspective article discusses how two different diseases, idiopathic multicentric Castleman disease (iMCD) and systemic lupus erythematosus (SLE), can look very similar in patients. They share many symptoms and lab findings, such as fevers, swollen lymph nodes, low blood cell counts, kidney problems, and high levels of inflammation. Some people with iMCD even have autoantibodies in their blood, which are typically associated with lupus. This overlap can make it hard to tell which condition a person has.
The key to getting the right diagnosis is examining a sample of tissue from a swollen lymph node under a microscope. This procedure, called a lymph node biopsy, is central to identifying iMCD. Without this step, a person might be misdiagnosed with lupus. The article notes that cases of iMCD might initially seem to meet the criteria for lupus but then not respond well to standard lupus treatments.
It is important to distinguish between these diseases because they are treated very differently. iMCD typically requires treatments that target specific inflammatory proteins called cytokines, while lupus is often managed with broader immunosuppressive drugs. Using the wrong treatment strategy could delay a patient's recovery. This article is not a new study, but a perspective meant to raise awareness among doctors about this diagnostic challenge to help improve patient care.